-
Annual General Meeting
The activity Purlin Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
-
Balance Sheet
Progress on Purlin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was documented.
-
Director Appointment
Falak Bagga was appointed as a Director was appointed as a Director on 21 Aug 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.
-
Director Appointment
Progress on Gaurav Bagga was appointed as a Director was appointed as a Director on 09 Feb 2017 & has been associated with this company since 8 years 11 months . was documented.
-
Company Incorporation
Progress on Purlin Pharma Private Limited was registered on 11 May 2016 with Roc Gwalior & aged 9 years 8 months as per MCA records. was documented.
Purlin Pharma Private Limited - Company Profile
Purlin Pharma Private Limited, a active private limited company, was established on 11 May 2016 in Indore, Madhya Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999MP2016PTC040720. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Gaurav Bagga (Director), Falak Bagga (Director). Past directors included Navin Chadha, Deepika Chadha, Monica Bagga. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 307, Princes Business Sky Line Block 32&33, Scheme No. 54, Vijay Nagar,, A.B. Road, Indore, Madhya Pradesh, 452010.
Company Details
- CIN/LLPIN
U74999MP2016PTC040720
- Registration Number
040720
- Incorporation Date
11 May 2016
- Authorized Capital
₹0.10 M
- Paid-Up Capital
₹0.10 M
- ROC Code
Roc Gwalior
-
Listing Status
Unlisted
- Company Status
Active
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -13.29%
- Profit Growth -60.45%
- Ebitda -53.84%
- Net Worth 163.85%
- Total Assets 32.62%
Purlin Pharma Private Limited
Company Report FY 2025-2026Comprehensive Company Insights
Explore comprehensive insights into Purlin Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav Bagga | Director | 09 Feb 2017 | Current |
| Falak Bagga | Director | 21 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jan 2023 | Past |
| Pramod Abcsdd | Director | 13 Jan 2023 | Past |
| Pramod Abcsdd | Director | 26 Apr 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Purlin Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.29% decrease. The company also saw a substantial fall in profitability, with a 60.45% decrease in profit. The company's net worth Soared by an impressive increase of 163.85%.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
******* |
******* |
******* |
******* |
||
| Revenue from Operations |
|
******* |
******* |
******* |
******* |
||
| Total Assets |
|
******* |
******* |
******* |
******* |
||
| Profit or Loss |
|
*******
|
*******
|
*******
|
*******
|
||
| Net Worth |
|
*******
|
*******
|
*******
|
*******
|
||
| EBITDA |
|
******* |
******* |
******* |
******* |
In 2018, Purlin Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
-
Promoters: 92.83%
-
Public: 4.10%
-
Others: 3.07%
| FY (2024) | FY (2023) | FY (2022) | FY (2021) | FY (2020) | |
|---|---|---|---|---|---|
| Promoters | 92.83 | 94.62 | 94.55 | 94.55 | 94.55 |
| Public | 4.10 | 3.89 | 3.95 | 3.96 | 3.98 |
| Others | 3.07 | 1.49 | 1.50 | 1.49 | 1.47 |
Reveal ownership structures and financial performance - Get instant access now!
Unlock and access historical data on people associated with Purlin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
| Employee Date | Number of Employees |
|---|---|
| 2020 | 78,000 |
| 2021 | 80,500 |
| 2022 | 83,200 |
| 2023 | 86,000 |
| 2024 | 89,500 |
| 2025 | 92,000 |
Gain comprehensive insights into the Deals and Valuation data of Purlin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purlin Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
What is the CIN of Purlin Pharma Private Limited?
The CIN of Purlin Pharma Private Limited is U74999MP2016PTC040720.
Where is Purlin Pharma Private Limited headquartered?
Purlin Pharma Private Limited is headquartered at 307, Princes Business Sky Line Block 32&33, Scheme No. 54, Vijay Nagar,, A.B. Road, Indore, Madhya Pradesh, 452010.
When was Purlin Pharma Private Limited incorporated?
Purlin Pharma Private Limited was incorporated on 11 May 2016.
Who are the current directors of Purlin Pharma Private Limited?
The current directors of Purlin Pharma Private Limited are
What is the primary industry of Purlin Pharma Private Limited?
The primary industry of Purlin Pharma Private Limited is Trade.
Is Purlin Pharma Private Limited a listed company?
Purlin Pharma Private Limited is unlisted.
What is the capital structure of Purlin Pharma Private Limited?
The authorized capital of Purlin Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
What is the compliance status of Purlin Pharma Private Limited?
The compliance status of Purlin Pharma Private Limited is Compliant.
+91-XXXXXXXXXX